US 7132420
Aspartic protease inhibitors
granted A61PA61P31/18
Quick answer
US patent 7132420 (Aspartic protease inhibitors) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P31/18